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On 6 June 2015, accidental aluminium phosphide (AlP) 
poisoning took four lives in the north-eastern Iranian city 
of Mashhad. The victims were Saudi Arabian tourists, 32 
of whom survived. This event attracted massive media 
attention (1), as recent tension in the Middle East led to 
implications of a terrorist attack, which was later dismissed. 
According to Iran’s Ministry of Interior, this accident was 
the result of “negligence and ignorance” (2).
In Asia, records of AlP suicide poisoning are not 
uncommon; AlP is cheap and available as a pesticide. It has 
been banned in Iran, except for specific use as rodenticide 
protecting stored rice and grain. Phosphine gas, as the main 
toxic agent, is released when phosphide comes in contact 
with moisture or acid (3). To the best of our knowledge, 
this is the first report of accidental outbreak of AlP poisoning 
through the air.
The aim of our investigation was to describe this 
poisoning outbreak from the public health emergency point 
of view. This report focuses on the pattern of referral and 
clinical findings that first responders should be aware of if 
they encounter an airborne AlP poisoning outbreak. The 
investigation followed the recommendations of the 
Mashhad University of Medical Sciences Ethics Committee 
for descriptive studies.
Case series
Thirty six Saudi tourists (mean age 15 years; range: 
1-45) staying in a hotel in Mashhad, Iran were admitted to 
the Imam Reza University Hospital for symptoms of acute 
AlP poisoning. One of them died en route to the hospital. 
They inhaled phosphine gas liberated from AlP powder 
which was placed in their rooms for pest control. Twelve 
patients were admitted between four and five a.m., 12 
between seven a.m. and one-thirty p.m., six between one-
thirty and seven-thirty p.m., and the remaining six patients 
after that time. The mean hospitalisation time was 1.5±0.8 
days (range: 0-2), including the self-discharged patients.
Four patients died before or soon (4-6 h) after admission 
despite all attempts at supportive treatment and were 
significantly younger than the surviving group (two less 
than one-year olds, one three-year old, and one 14-year 
old). Gas chromatography with a nitrogen phosphorous 
detector of the vomit and gastric secretions of the deceased 
patients confirmed phosphine exposure. The main clinical 
manifestation of three deceased patients on admission was 
shock and severe metabolic acidosis, which was refractory 
to treatment by volume expander sera and sodium 
bicarbonate with close monitoring of arterial blood gases 
and serum electrolyte balance. In addition to shock, the 
fourth deceased patient had a massive pulmonary 
haemorrhage due to disseminated intravascular coagulation 
(DIC). All deceased patients were unresponsive or barely 
responsive to painful stimuli on admission, whereas all 
surviving patients were alert on admission. We find this 
information potentially useful for triage and rapid 
intervention.
Of the 32 survivors, 21 were men and nine women (two 
of them pregnant). All survivors had increased heart rate 
(94 to 120 beats per min) on admission. Two had systolic 
blood pressure <90 mmHg and mild metabolic acidosis that 
turned back to normal on the first day in hospital. They 
received serum therapy with normal saline, infusion of N 
acetyl cysteine, and Mg SO4 in addition to other antioxidant 
drugs such as vitamins E and C. Echocardiography was 
performed for all 32 survivors and all had normal left 
ventricular ejection fraction. All survivors were alert 
throughout hospitalisation. On admission their mean arterial 
pH, HCO3, and CO2 were 7.36±0.04 (7.29-7.42), 19.8±3.7 
(13.3-28.4), and 33.3±6.6 (20.0-46.3), respectively. Blood 
sugar, serum electrolytes, urea, and creatinine were within 
normal ranges. Late admission to the hospital inversely 
correlated with days of hospitalisation (r=-0.393) and 
arterial pH (r=-0.291), HCO3 (r=-0.227), and CO2 (r=- 
0.166). Most survivors were anxious, which was the main 
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reason for tachycardia without any other aetiology, such as 
hypotension or infection.
DISCUSSION
Our motive to report on this incident was to take a public 
health emergency point of view that could be useful for first 
responders who may find themselves in a similar situation, 
as this may not be the last airborne outbreak of AlP 
poisoning, at least in countries where AlP is still used. In 
addition, we wanted to show that the pattern of referrals 
differed for severe and mild cases. In the early stage of the 
outbreak, severe cases were admitted first, and as the time 
passed milder cases were admitted, many of whom had 
minimal symptoms, but also symptoms related to panic.
Suicidal or accidental poisoning with aluminium 
phosphide (AlP) has become rather notorious in Iran and 
other Asian countries over the past few decades. Phosphide 
in contact with moisture or acid releases a colourless, highly 
toxic and flammable phosphine gas, which has an odour of 
decaying fish or garlic (4-6).
Even though the exact mechanism of phosphine gas 
toxicity is still poorly explained, we believe that it inhibits 
cytochrome c oxidase and causes oxidative stress followed 
by severe mitochondrial dysfunction, impaired cellular 
respiration, tissue hypoxia, and eventually multiple organ 
damage (5, 7).
Patients mostly present with gastrointestinal symptoms, 
refractory hypotension, severe metabolic acidosis, and atrial 
and ventricular dysrhythmia. Less common are acute 
respiratory distress syndrome, acute tubular necrosis, 
d i s s e m i n a t e d  i n t r a v a s c u l a r  c o a g u l a t i o n , 
methaemoglobinaemia, and metabolic disorders (7).
Even if AlP is not ingested, phosphine gas inhalation 
can lead to severe toxicity, even in large spaces (7, 8) as the 
Mashhad hotel incident confirms.
Unfortunately, there is still no definitive management 
or specific antidote for this rapidly progressing poisoning, 
and treatment remains mainly supportive. Immediate 
diagnosis and continued intensive supportive measures are 
critical in the management of AlP poisoning.
Field inspections revealed that the hotel employees used 
AlP powder as a rodenticide. They were later arrested and 
accused of manslaughter. The main issues this tragedy has 
raised is that AlP is readily available and that users are 
poorly informed about safe use and the associated risks, 
both of which can be completely addressed and further 
tragedies prevented.
Although airborne AlP poisoning is highly fatal, we 
noticed that the patients who were admitted while they were 
rather alert and who received extensive care survived.
Health promotion policies should focus on both general 
public and AlP users if the total ban is not possible. First 
responders should receive training to recognise clinical 
signs and symptoms of airborne AlP poisoning and respond 
quickly and appropriately.
Considering the highly fatal nature of this agent and 
potential use in terrorist attacks, regulatory strategies and 
action plans for controlled AlP distribution should be 
enforced all over the world.
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